Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3131)	1/7/2011 10:53:36 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

OPK had already reported its research in AD in February last year.<g> investor.opko.com But the presentations at UBS and Lazard, and the recent publication of an article in Cell, are now causing more comments about it in the media and that research is having a wider exposure, as the company also made further emphasis on it. <g> finance.yahoo.com This is a comment on Fox News: foxnews.com As mentioned yesterday,the B/A wasn't good at the close, but the stock did well AHs.<g> The stock has been making 52wks Hs. The CEO has continued his steady buying.<g> OPK is scheduled to have a presentation at J.P.Morgan on Monday after the market closes. There is no ACTAY I will keep a TT at $5 pending further developments.<g> bigcharts.marketwatch.com Disclosure: I remain long OPK Bernard